Renal transplantation in HIV patients: A series of four cases

Indian Journal of Nephrology

Volumn 22, Issue 2, 2012, Pages 139-142

  Agarwal, D ^a   Hota, J ^a   Nag, N ^a   Mehta, S ^a  

^a INDRAPRASTHA APOLLO HOSPITAL   (India)

Author keywords

End stage renal disease; highly active antiretroviral therapy; human immunodeficiency virus; immunosuppression

Indexed keywords

ABACAVIR; ANTIBIOTIC AGENT; BASILIXIMAB; CREATININE; CYCLOSPORIN; EFAVIRENZ; LAMIVUDINE; LOPINAVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; RITONAVIR; STAVUDINE; STEROID; TACROLIMUS;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG PULSE THERAPY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALE; PATIENT COMPLIANCE; POSTOPERATIVE PERIOD; PROPHYLAXIS;

EID: 84862748920     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.97139     Document Type: Article

References (24)

1. Spital A. Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation? The views of US transplant centres. Transplantation 1998;65:1187-91.
2. Kumar MS, Sierka DR, Damask AM, Fyfe B, McAlack RF, Heifets M, et al. Safety and success of kidney transplantation and concomitant immunosuppression in HIV- positive patients. Kidney Int 2005;67:1622-9.
3. Coffiman K. Evidence-based medicine: The dilemma of transplantation in patients with HIV infection. Cur Opn Organ Transplant 2004;9:422-7.
4. Abbott KC, Swanson SJ, Agodoa LY, Kimmel PL. Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression. J Am Soc Nephro 2004;15:1633-9.
5. Halpern SD, Ubel PA, Caplan Al. Solid organ transplant in HIV infected patients. N Engl J Med 2002;347:284-7.
6. Murphy B, Carlson L, Ronal S, Keller M, Lu A, Kumar MSA, et al. Renal transplantation in HIV infected recipients - 23 cases in the HAART era. J Am Soc Neph 2002;13:11-3.
7. Palella FJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006;43:27-34.
8. Roland ME, Stock PG. Review of solid-organ transplantation in HIV-infected patients. Transplatation 2003;75:425-9.
9. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004;66:1145-52.
10. Karpan A, lawdell M, Jacobson SK, Hill F. Inhibition of human immunosuppressive drugs cyclosporine A and FK 506. ProcNatl Head Sci USA 1992;89:8351-5.
11. Protocol HIVTR: Solid Organ Transplantation in HIV: Multi-Site Study[online], Available from: http://www.HIVtransplant.com [Last accessed on 2009].
12. Bhagani S. Sweny P Written on behalf of the British HIV Association and reviewed and endorsed by the British Transplantation Society Standards Committee Available from: http://www.bts.org.uk/from hiv-renal transplant [Last accessed Dec 2009].
13. Frassetto LA, Tan-Tam C, Stock PG. Stock renal transplantation in patients with HIV. Nat Rev Nephrol 2009;5:582-9.
14. Huisman MT, Smit JW, Schinkel AH. Significance of P - glycoprotein for the pharmacology and clinical use of HIV protease inhibitors. AIDS 2000;14:237-42.
15. Profit L, Eagling VA, Back DJ. Modulation of P - glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV- 1 protease inhibitors. AIDS 1999;13:1623-7.
16. Srinivas RV, Middlemas D, Flynn P, Fridland A. Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins. MDR1and MRP1 but retain antiviral efficacy in cell lines expressing these transporters. Antimicrob Agents Chemother 1998;42:3157-62.
17. Rizzardi GP, Harari A, Capiluppi B, Tambussi G, Ellefsen K, Ciuffreda D, et al. Treatment of primary HIV-1 infection with cyclosporine A coupled with highly active antiretroviral therapy. J Clin Invest 2002;109:681-8.
18. Frassetto LA, Browne M, Cheng A, Wolfe AR, Roland ME, Stock PG, et al. Immunosuppressant pharmacokinetics and dosing modification in HIV-1 infected liver and kidney transplant recipients. Am J Transplant 2007;7:2816-20.
19. Izzedine H, Launay-Vacher V, Baumelou A, Deray G. Antiretroviral and immunosuppressive drug-drug interactions: an update. Kidney Int 2004;66:532-41.
20. Bansal SB, Singhal M, Ahlawat R, Kher V. Kidney transplantation in a patient with HIV disease. Indian J Nephrol 2009;19:77-9.
21. Moscoso-Solorzano GT, Baltar JM, Seco M, López-Larrea C, Mastroianni-Kirsztajn G, Ortega F. Single dose of rituximab plus plasmapheresis in an HIV patient with acute humoral kidney transplant rejection: A case report.Transplant proceedings 2007;39:3460-2.
22. Qiu J, Terasaki PI, Waki K, Cai J, Gjertson DW. HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients. Transplantation 2006;8:1658-61.
23. Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, et al. HIV-infected liver and kidney transplant recipients: 1-and 3-year outcomes. Am J Transplant 2008;8:355-65.
24. Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation 2003;76:370-5.